Latest Research

There’s new, exciting, and groundbreaking research on the horizon for SADS conditions. At the SADS Foundation, we’re working with companies who are almost ready to recruit participants for first-of-their-kind clinical trials for these new therapies.

Take the Research Survey

Below are a few upcoming research opportunities. 

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)